François Bouzom

Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor

Grégory Hamm, David Bonnel, Raphaël Legouffe et al. · Journal of Proteomics · 2012 · 196 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Effect of Variations in the Amounts of P-Glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the Human Small Intestine on PBPK Models for Predicting Intestinal First Pass

Arnaud Bruyère, Xavier Declèves, François Bouzom et al. · Molecular Pharmaceutics · 2010 · 99 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Mike F. Burbridge, Céline Bossard, Carine Saunier et al. · Molecular Cancer Therapeutics · 2013 · 87 citations

Medicine, Oncology, Pharmacology +17

Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation

Terry Shepard, Graham Scott, Susan Cole et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 73 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling

Nathalie Perdaems, Hélène Blasco, Cédric Vinson et al. · Clinical Pharmacokinetics · 2010 · 62 citations

Pharmacy, Pharmacokinetics, Pharmacology +12